These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 18359309

  • 21. Prognostic impact of moderate renal dysfunction in acute coronary syndromes.
    Nabais S, Rocha S, João C, Marques J, Torres M, Magalhães S, Pereira MA, Correia A.
    Rev Port Cardiol; 2008 Mar; 27(3):303-12; discussion 315-7. PubMed ID: 18551917
    [Abstract] [Full Text] [Related]

  • 22. Prognostic implications of renal dysfunction in patients with stable angina pectoris.
    Almquist T, Forslund L, Rehnqvist N, Hjemdahl P.
    J Intern Med; 2006 Dec; 260(6):537-44. PubMed ID: 17116004
    [Abstract] [Full Text] [Related]

  • 23. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M, Noberasco G, Re M, Filippi A, Gallina AM, Weiss U, Cannavò R, Ravera G, Cricelli C, Deferrari G.
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [Abstract] [Full Text] [Related]

  • 24. Renal function and outcomes in acute coronary syndrome: impact of clopidogrel.
    Keltai M, Tonelli M, Mann JF, Sitkei E, Lewis BS, Hawken S, Mehta SR, Yusuf S, CURE Trial Investigators.
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):312-8. PubMed ID: 17446813
    [Abstract] [Full Text] [Related]

  • 25. Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial.
    Moukarbel GV, Signorovitch JE, Pfeffer MA, McMurray JJ, White HD, Maggioni AP, Velazquez EJ, Califf RM, Scheiman JM, Solomon SD.
    Eur Heart J; 2009 Sep; 30(18):2226-32. PubMed ID: 19556260
    [Abstract] [Full Text] [Related]

  • 26. Combined impact of age and estimated glomerular filtration rate on in-hospital mortality after percutaneous coronary intervention for acute myocardial infarction (from the American College of Cardiology National Cardiovascular Data Registry).
    Cardarelli F, Bellasi A, Ou FS, Shaw LJ, Veledar E, Roe MT, Morris DC, Peterson ED, Klein LW, Raggi P.
    Am J Cardiol; 2009 Mar 15; 103(6):766-71. PubMed ID: 19268729
    [Abstract] [Full Text] [Related]

  • 27. Renal dysfunction predicts long-term mortality in patients with lower extremity arterial disease.
    Pasqualini L, Schillaci G, Pirro M, Vaudo G, Siepi D, Innocente S, Ciuffetti G, Mannarino E.
    J Intern Med; 2007 Dec 15; 262(6):668-77. PubMed ID: 17908164
    [Abstract] [Full Text] [Related]

  • 28. Renal function and risk of myocardial infarction in an elderly population: the Rotterdam Study.
    Brugts JJ, Knetsch AM, Mattace-Raso FU, Hofman A, Witteman JC.
    Arch Intern Med; 2007 Dec 15; 165(22):2659-65. PubMed ID: 16344425
    [Abstract] [Full Text] [Related]

  • 29. Impact of reduced renal function on prognosis in Japanese patients with coronary artery disease: a prospective cohort of Shinken Database 2007.
    Nakamura M, Yamashita T, Yajima J, Oikawa Y, Ogasawara K, Kirigaya H, Sagara K, Koike A, Sawada H, Aizawa T.
    Hypertens Res; 2009 Oct 15; 32(10):920-6. PubMed ID: 19696780
    [Abstract] [Full Text] [Related]

  • 30. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
    Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Køber L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM, Valsartan in Acute Myocardial Infarction Trial Investigators.
    N Engl J Med; 2003 Nov 13; 349(20):1893-906. PubMed ID: 14610160
    [Abstract] [Full Text] [Related]

  • 31. Renal function predicts cardiovascular outcomes in southern Italian postmenopausal women.
    Perticone F, Sciacqua A, Maio R, Perticone M, Laino I, Bruni R, Cello SD, Leone GG, Greco L, Andreozzi F, Sesti G.
    Eur J Cardiovasc Prev Rehabil; 2009 Aug 13; 16(4):481-6. PubMed ID: 19531955
    [Abstract] [Full Text] [Related]

  • 32. Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial.
    Solomon SD, Rice MM, A Jablonski K, Jose P, Domanski M, Sabatine M, Gersh BJ, Rouleau J, Pfeffer MA, Braunwald E, Prevention of Events with ACE inhibition (PEACE) Investigators.
    Circulation; 2006 Jul 04; 114(1):26-31. PubMed ID: 16801465
    [Abstract] [Full Text] [Related]

  • 33. High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
    Anderson RE, Pfeffer MA, Thune JJ, McMurray JJ, Califf RM, Velazquez E, White HD, Rouleau JL, Skali H, Maggioni A, Solomon SD.
    Am Heart J; 2008 Apr 04; 155(4):706-11. PubMed ID: 18371480
    [Abstract] [Full Text] [Related]

  • 34. Heart attack patients with complications. Treat with valsartan, captopril, or both?
    Nguyen A, Sharma S.
    Can Fam Physician; 2004 Aug 04; 50():1093-5. PubMed ID: 15455807
    [No Abstract] [Full Text] [Related]

  • 35. Renal transplant dysfunction--importance quantified in comparison with traditional risk factors for cardiovascular disease and mortality.
    Soveri I, Holdaas H, Jardine A, Gimpelewicz C, Staffler B, Fellström B.
    Nephrol Dial Transplant; 2006 Aug 04; 21(8):2282-9. PubMed ID: 16574686
    [Abstract] [Full Text] [Related]

  • 36. Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    Reed SD, Radeva JI, Weinfurt KP, McMurray JJ, Pfeffer MA, Velazquez EJ, Allsbrook JS, Masselink LE, Sellers MA, Califf RM, Schulman KA, VALIANT Investigators.
    Am Heart J; 2005 Aug 04; 150(2):323-9. PubMed ID: 16086938
    [Abstract] [Full Text] [Related]

  • 37. Declining renal function after myocardial infarction predicts poorer long-term outcome.
    Aengus Murphy C, Robb SD, Weir RA, McDonagh TA, Dargie HJ.
    Eur J Cardiovasc Prev Rehabil; 2010 Apr 04; 17(2):181-6. PubMed ID: 19829117
    [Abstract] [Full Text] [Related]

  • 38. Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART).
    Szummer K, Lundman P, Jacobson SH, Schön S, Lindbäck J, Stenestrand U, Wallentin L, Jernberg T, SWEDEHEART.
    Circulation; 2009 Sep 08; 120(10):851-8. PubMed ID: 19704097
    [Abstract] [Full Text] [Related]

  • 39. Renal dysfunction predicts attenuation of ischemic heart disease mortality risk from elevated glucose among treated hypertensive patients.
    Hailpern SM, Cohen HW, Alderman MH.
    Am J Hypertens; 2006 Oct 08; 19(10):998-1004. PubMed ID: 17027817
    [Abstract] [Full Text] [Related]

  • 40. Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study.
    Stam F, van Guldener C, Becker A, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD.
    J Am Soc Nephrol; 2006 Feb 08; 17(2):537-45. PubMed ID: 16382015
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.